SPAI compared with AIDX: revenue, margins and what each company keeps, and the suppliers and customers both name

SPAISafe Pro Group Inc.

Mkt capRevenueRevenue

AIDX20/20 Biolabs, Inc.

Mkt capRevenueRevenue

Compare

SPAISafe Pro Group Inc.

AIDX20/20 Biolabs, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

SPAI2 of 4 reports

1 of 1at or beyond implied

Reportimpliedrealized× implied

Oct 7 '26—▲+14.88%—

Q2 FY26±16.1%▲+37.72%×2.34

AIDX1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▼−6.21%—

= impliedSPAI realized, solidAIDX realized, hatchedOne scale, both sides: full bar = 38%× = |realized| ÷ impliedSource: market data

SPAISafe Pro Group Inc.

3.06▲+10.87%· post 3.11

Mkt cap$63.4MRevenue$1MQ2 FY26Revenue$606,681FY25

AIDX20/20 Biolabs, Inc.

0.24▲+28.73%· post 0.20

ClosedNov 6 '26

Mkt cap$2.1MRevenue$730,571Q2 FY26Revenue—

Compare

ClosedNov 6 '26

SPAISafe Pro Group Inc.

AIDX20/20 Biolabs, Inc.

3.06▲+10.87%post 3.11

Price

0.24▲+28.73%post 0.20

$63.4M

Mkt cap

$2.1M

Q2 FY26$1M

Revenue

$730,571Q2 FY26

FY25$606,681

Revenue

—

SPAI3.06▲+10.87%vsAIDX0.24▲+28.73%ClosedNov 6 '26